Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape von Das, Rituparna, Hyer, Randall N., Burton, Paul, Miller, Jacqueline M., Kuter, Barbara J.

Volltext

Author reply to "Heterologous mRNA-based COVID-19 booster strategies: Comment" von Das, Rituparna, Hyer, Randall N., Burton, Paul, Miller, Jacqueline M., Kuter, Barbara J.

Volltext

Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years von Hyer, Randall N, Janssen, Robert S

Volltext

Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations von Hirst, Alex, Hyer, Randall N., Janssen, Robert S.

Volltext

An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysis von Awad, Ahmed M., Ntoso, Adu, Connaire, Jeffrey J., Hernandez, German T., Dhillon, Kiranjit, Rich, Lisa, Henderson, Heather, Lynn, Robert, Hyer, Randall N., Xie, Fang, Erby, Kimberly, Janssen, Robert S.

Volltext

Department of Defense Global Emerging Infections Surveillance and Response System Indian Ocean tsunami response von Chretien, Jean-Paul, Glass, Jonathan S, Coldren, Rodney C, Noah, Donald L, Hyer, Randall N, Gaydos, Joel C, Malone, Joseph L

Volltext

HBsAg-1018, a Two-Dose Hepatitis B Vaccine, Is Well Tolerated and Effective in Diabetic Patients Aged 60 Years or Older von HYER, RANDALL N., JANSSEN, ROBERT S.

Volltext

2287. Recently Approved HEPLISAV-B(R) [Hepatitis B Vaccine (Recombinant), Adjuvanted] Shows a Higher Proportion of Subjects Achieving Seroprotection With a More Consistent Immune R... von Hyer, Randall N, Janssen, Robert

Volltext

286. Hepatitis B Vaccine Compliance: Comparing 2-Dose and 3-Dose Vaccines von Bruxvoort, Katia, Slezak, Jeff, Huang, Runxin, Sy, Lina S, Towner, William, Ackerson, Bradley, Reynolds, Kristi, Qian, Lei, Carlson, Cheryl M, Solano, Zendi, Hyer, Randall N, Janssen, Robert, Jacobsen, Steven J

Volltext

Be prepared to use the hot mic to counter pandemics von Hyer, Randall N

Volltext

International Response to Disease Epidemics—Lessons From SARS von Hyer, Randall N.

Volltext

COVID-19 and the Seven Pillars of Effective Risk and Crisis Communication von Covello, Vincent T., Hyer, Randall N.

Volltext

SHINGLES VACCINES COMPRISING A TLR9 AGONIST von JANSSEN, Robert S, CAMPBELL, John D, HYER, Randall N, NOVACK, David

Volltext bestellen

SHINGLES VACCINES COMPRISING A TLR9 AGONIST von JANSSEN, Robert S, CAMPBELL, John D, HYER, Randall N, NOVACK, David

Volltext bestellen

SHINGLES VACCINES COMPRISING A TLR9 AGONIST von JANSSEN, Robert S, CAMPBELL, John D, HYER, Randall N, NOVACK, David

Volltext bestellen

Shingles vaccines comprising a TLR9 agonist von JANSSEN, Robert S, CAMPBELL, John D, HYER, Randall N, NOVACK, David

Volltext bestellen

ACTIVE BOOSTER IMMUNIZATION AGAINST TETANUS, DIPHTHERIA AND PERTUSSIS von URBAN, Maureen, COFFMAN, Robert L, JANSSEN, Robert S, GAIROLA, Sunil, SHALIGRAM, Umesh, CAMPBELL, John D, RAO, Harish, HYER, Randall N, GOHLKE, Martin, NOVACK, David, GAUTUM, Manish

Volltext bestellen

Cost-effectiveness analysis of reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits von Hyer, RN, Howell, MR, Ryan, MA, Gaydos, JC

Volltext

SHINGLES VACCINES COMPRISING A TLR9 AGONIST von JANSSEN, Robert S, CAMPBELL, John D, HYER, Randall N, NOVACK, David

Volltext bestellen

SHINGLES VACCINES COMPRISING A TLR9 AGONIST von JANSSEN, ROBERT S, HYER, RANDALL N, CAMPBELL, JOHN D, NOVACK, DAVID

Volltext bestellen